Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

von Eckardstein A, Nofer JR, Assmann G. High density lipoproteins and arteriosclerosis. role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001;21(1):13–27.

Rye KA, Barter PJ. Cardioprotective functions of HDLs. J Lipid Res. 2014;55(2):168–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mora S, Buring JE, Ridker PM, Cui Y. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study. Ann Intern Med. 2011;155(11):742–50.

Article  PubMed  PubMed Central  Google Scholar 

Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004;96(15):1152–60.

Article  CAS  PubMed  Google Scholar 

Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjønneland A, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2007;14(3):755–67.

Article  CAS  PubMed  Google Scholar 

Ahn J, Lim U, Weinstein SJ, Schatzkin A, Hayes RB, Virtamo J, et al. Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2814–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol. 2008;18(9):671–7.

Article  PubMed  PubMed Central  Google Scholar 

Martin LJ, Melnichouk O, Huszti E, Connelly PW, Greenberg CV, Minkin S, et al. Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points. J Natl Cancer Inst. 2015;107(5):djv032.

Article  PubMed  PubMed Central  Google Scholar 

Youn Nam S, Park BJ, Nam JH, Ryu KH, Kook MC, Kim J, et al. Association of current Helicobacter pylori infection and metabolic factors with gastric cancer in 35,519 subjects: a cross-sectional study. United European Gastroenterol J. 2019;7(2):287–96.

Article  PubMed  Google Scholar 

Nam SY, Park BJ, Nam JH, Kook MC. Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development. Gastrointest Endosc. 2019;90(3):448-56.e1.

Article  PubMed  Google Scholar 

Pedersen KM, Çolak Y, Bojesen SE, Nordestgaard BG. Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals. J Hematol Oncol. 2020;13(1):129.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim JH, Shin CM, Han K, Yoo J, Jin EH, Choi YJ, et al. Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women. Gastric Cancer. 2022;25(1):11–21.

Article  CAS  PubMed  Google Scholar 

Costa AR, Lança de Oliveira M, Cruz I, Gonçalves I, Cascalheira JF, Santos CRA. The sex bias of cancer. Trends Endocrinol Metab 2020;31(10):785–99.

Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 2014;384(9945):755–65.

Wulaningsih W, Garmo H, Holmberg L, Hammar N, Jungner I, Walldius G, et al. Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS Study. J Cancer Epidemiol. 2012;2012: 792034.

PubMed  PubMed Central  Google Scholar 

Lee JE, Han K, Yoo J, Yeo Y, Cho IY, Cho B, et al. Association between metabolic syndrome and risk of esophageal cancer: a nationwide population-based study. Cancer Epidemiol Biomarkers Prev. 2022;31(12):2228–36.

Article  CAS  PubMed  Google Scholar 

Jung W, Jeon KH, Kang J, Choi T, Han K, Jin SM, et al. Association between cholesterol level and the risk of hematologic malignancy according to menopausal status: a Korean Nationwide Cohort Study. Biomedicines. 2022;10(7):1617.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Catapano AL, Pirillo A, Bonacina F, Norata GD. HDL in innate and adaptive immunity. Cardiovasc Res. 2014;103(3):372–83.

Article  CAS  PubMed  Google Scholar 

Gomaraschi M. Role of Lipoproteins in the microenvironment of hormone-dependent cancers. Trends Endocrinol Metab. 2020;31(3):256–68.

Article  CAS  PubMed  Google Scholar 

Mihajlovic M, Gojkovic T, Vladimirov S, Miljkovic M, Stefanovic A, Vekic J, et al. Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer. Clin Biochem. 2019;63:32–8.

Article  CAS  PubMed  Google Scholar 

Pirro M, Ricciuti B, Rader DJ, Catapano AL, Sahebkar A, Banach M. High density lipoprotein cholesterol and cancer: marker or causative? Prog Lipid Res. 2018;71:54–69.

Article  CAS  PubMed  Google Scholar 

Sugano M, Tsuchida K, Makino N. High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Biochem Biophys Res Commun. 2000;272(3):872–6.

Article  CAS  PubMed  Google Scholar 

Jung HK, Tae CH, Lee HA, Lee H, Don Choi K, Park JC, et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: a nationwide cohort study of 6,354 Korean patients. PLoS ONE. 2020;15(4): e0231456.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rumgay H, Arnold M, Laversanne M, Whiteman DC, Thrift AP, Wei W, et al. International trends in esophageal squamous cell carcinoma and adenocarcinoma incidence. Am J Gastroenterol. 2021;116(5):1072–6.

Article  PubMed  Google Scholar 

Lin Y, Wang HL, Fang K, Zheng Y, Wu J. International trends in esophageal cancer incidence rates by histological subtype (1990–2012) and prediction of the rates to 2030. Esophagus. 2022;19(4):560–8.

Article  PubMed  Google Scholar 

Borena W, Stocks T, Jonsson H, Strohmaier S, Nagel G, Bjørge T, et al. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control. 2011;22(2):291–9.

Article  PubMed  Google Scholar 

Guan XM, Wu SL, Yang XL, Han X, Yang YH, Li XT, et al. Association of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population. Int J Cancer. 2018;142(6):1209–17.

Article  CAS  PubMed  Google Scholar 

Yoon YA, Lee YW, Kim S, Lee K, Park HD, Chun S, et al. Standardization status of total cholesterol concentration measurement: analysis of Korean External Quality Assessment Data. Ann Lab Med. 2021;41(4):366–71.

Article  PubMed  PubMed Central  Google Scholar 

Sundvall J, Leiviskä J, Alfthan G, Vartiainen E. Serum cholesterol during 27 years: assessment of systematic error and affecting factors and their role in interpreting population trends. Clin Chim Acta. 2007;378:93–8.

Article  CAS  PubMed  Google Scholar 

Ross JW, Miller WG, Myers GL, Praestgaard J. The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologist Chemistry Survey with fresh frozen serum, definitive methods, and reference methods. Arch Pathol Lab Med. 1998;122:587–608.

CAS  PubMed  Google Scholar